Posted in | News | Nanoanalysis

Senior Application Scientist at Malvern Instruments to Present a Paper at ISEV 2014

Pauline Carnell, Senior Application Scientist at Malvern Panalytical, will present a paper at ISEV 2014 discussing The practical use of nanoparticle tracking analysis (NTA) to characterise extracellular vesicles in general and when using fluorescence markers’.

ISEV 2014 is a meeting of the International Society for Extracellular Vesicles. It takes place in Rotterdam, The Netherlands, from 30 April to 3 May 2014, with an education day on 29 April. Pauline Carnell will present the paper, co-authored with colleagues Andrew Malloy, Agnieszka Siupa, Patrick Hole and Bob Carr, on 30 April. All the authors are experts in the technology and application of NanoSight Nanoparticle Tracking Analysis (NTA). NanoSight NTA systems are now offered as part of Malvern Panalytical’s portfolio of analytical solutions for characterization at the nanoscale and Malvern Panalytical is a sponsor for ISEV 2014: http://www.isevmeeting.org/

Extracellular vesicles, typically 30 to 100 nm, are released within and from a wide variety of cells. They are increasingly implicated and appear in a multitude of pathological conditions and show much promise as diagnostics for many different diseases including cancer, heart disease, diabetes, Alzheimer's and pre-eclampsia. However, developments in this area are constrained by limitations in the technology available for their measurement.

NanoSight Nanoparticle Tracking Analysis offers the potential to rapidly enumerate and speciate these particles. In this method the particles in suspension scatter laser light, which is collected by a CCD (or sCMOS) camera via a microscope-type configuration. Particles are tracked individually and their diffusion coefficient, and therefore size, calculated directly from their speed. This gives a direct measurement of the concentration and size distribution of the particles in the field of view.

Fluorescent labelling of particles for expressed markers enables measurement of the concentration and size distribution of those labelled particles only, allowing the proportion of labelled particles to be calculated. Pauline Carnell’s presentation will examine some of the challenges and considerations required during protocol development and measurement, and will include examples of good methodologies and appropriate controls.

For details of ISEV 2014 go to http://www.isev.org/

Download the latest white paper on Nanoparticle Tracking Analysis for Extracellular Vesicles at http://bit.ly/MALEV

Malvern Panalytical, Malvern Panalytical and NanoSight are registered trademarks of Malvern Panalytical

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2019, February 11). Senior Application Scientist at Malvern Instruments to Present a Paper at ISEV 2014. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=29591.

  • MLA

    Malvern Panalytical. "Senior Application Scientist at Malvern Instruments to Present a Paper at ISEV 2014". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=29591>.

  • Chicago

    Malvern Panalytical. "Senior Application Scientist at Malvern Instruments to Present a Paper at ISEV 2014". AZoNano. https://www.azonano.com/news.aspx?newsID=29591. (accessed November 21, 2024).

  • Harvard

    Malvern Panalytical. 2019. Senior Application Scientist at Malvern Instruments to Present a Paper at ISEV 2014. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=29591.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.